These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 6765520)
21. Comparative double-blind trial of the effectiveness and antigenicity of semisynthetic human insulin and purified porcine insulin in newly treated diabetic subjects. Larkins RG; Zajac J; Saunders R; Read A; Hopper JL Aust N Z J Med; 1986 Apr; 16(2):206-10. PubMed ID: 3530226 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and immunogenicity of human and monocomponent porcine insulin: a randomized double-blind study in diabetic patients previously treated with insulin. Storms GE; Lutterman JA; van 't Laar A Neth J Med; 1986; 29(10):296-302. PubMed ID: 3540688 [No Abstract] [Full Text] [Related]
23. Correlation between HbA1c, purified insulins, diabetic control, and insulin antibodies in diabetic children. Bistritzer T; Sack J; Theodor R; Weissglass L; Ben-Bassat I; Lahav M Horm Res; 1984; 20(3):178-85. PubMed ID: 6386647 [TBL] [Abstract][Full Text] [Related]
24. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects. Schloot NC; Roep BO; Wegmann D; Yu L; Chase HP; Wang T; Eisenbarth GS Diabetologia; 1997 May; 40(5):564-72. PubMed ID: 9165225 [TBL] [Abstract][Full Text] [Related]
25. [Avidity and binding capacity of bovine and porcine insulin binding antibodies in childhood diabetes]. Hürter P; Kühnau J Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):250-2. PubMed ID: 5535600 [No Abstract] [Full Text] [Related]
26. The antibody response to insulin therapy. A prospective study in HLA-typed insulin-dependent diabetic subjects. Asplin CM; Dornan TL; Raghu PK; Hansen JA; Palmer JP Diabetes; 1984 Oct; 33(10):966-9. PubMed ID: 6383905 [TBL] [Abstract][Full Text] [Related]
27. A human anti-insulin IgG autoantibody apparently arises through clonal selection from an insulin-specific "germ-line" natural antibody template. Analysis by V gene segment reassortment and site-directed mutagenesis. Ichiyoshi Y; Zhou M; Casali P J Immunol; 1995 Jan; 154(1):226-38. PubMed ID: 7995943 [TBL] [Abstract][Full Text] [Related]
28. A prospective study of the immunogenicity of porcine insulin in HLA-typed new insulin-treated diabetics. Almér LO; Ekberg G; Fankhauser S; Home PD; Worth R; Sailer S; Kurtz AB; Christy M Diabetes Res; 1985 Sep; 2(5):221-4. PubMed ID: 3905185 [TBL] [Abstract][Full Text] [Related]
29. Immunogenicity of biosynthetic human insulin. Humoral immune response in diabetic patients beginning insulin treatment and in patients previously treated with other insulins. Di Mario U; Arduini P; Tiberti C; Lombardi G; Pietravalle P; Andreani D Diabetes Res Clin Pract; 1986; 2(6):317-24. PubMed ID: 3545723 [TBL] [Abstract][Full Text] [Related]
30. Immunologic improvement resulting from the transfer of animal insulin-treated diabetic subjects to human insulin (recombinant DNA). Fineberg SE; Galloway JA; Fineberg NS; Rathbun MJ Diabetes Care; 1982; 5 Suppl 2():107-13. PubMed ID: 6765519 [TBL] [Abstract][Full Text] [Related]
31. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals. Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038 [TBL] [Abstract][Full Text] [Related]
32. Successful treatment of immune-mediated insulin resistance by human insulin (recombinant DNA). Maneschi F; Fineberg SE; Kohner EM Diabetes Care; 1982; 5 Suppl 2():175-9. PubMed ID: 6765532 [TBL] [Abstract][Full Text] [Related]
33. IgE and IgG antibody against human (recombinant DNA) insulin in patients with systemic insulin allergy. Grammer LC; Roberts M; Patterson R J Lab Clin Med; 1985 Jan; 105(1):108-13. PubMed ID: 3881543 [TBL] [Abstract][Full Text] [Related]
34. The immunogenicity of insulin preparation. Antibody levels before and after transfer to highly purified porcine insulin. Heding LG; Larsson Y; Ludvigsson J Diabetologia; 1980; 19(6):511-5. PubMed ID: 7007131 [No Abstract] [Full Text] [Related]
35. Decrease of circulating insulin antibodies in two patients treated with continuous subcutaneous infusion of human insulin (recombinant DNA). Spijker AJ; Poortman J; Thijssen JH; Erkelens DW Diabetes Care; 1982; 5 Suppl 2():171-4. PubMed ID: 6765531 [TBL] [Abstract][Full Text] [Related]
36. Total IgG and IgG subclass specific antibody responses to insulin in diabetic patients. Soto-Aguilar MC; deShazo RD; Morgan JE; Mather P; Ibrahim G; Frentz JM; Lauritano AA Ann Allergy; 1991 Nov; 67(5):499-503. PubMed ID: 1958003 [TBL] [Abstract][Full Text] [Related]
37. Application of a rapid enzyme-linked immunosorbent microassay (ELISA) to study human anti-insulin antibody. Nell LJ; Virta VJ; Thomas JW Diabetes; 1985 Jan; 34(1):60-6. PubMed ID: 3880549 [TBL] [Abstract][Full Text] [Related]
38. [Desensitization to human recombinant DNA insulin in an adolescent with insulin-dependent diabetes mellitus]. Rosas Vargas MA; Alvarez Amador M; Alvarez Amador LM; del Río Navarro BE; Avila Castanón L; Sienra Monge JJ Rev Alerg Mex; 2001; 48(5):129-32. PubMed ID: 11759253 [TBL] [Abstract][Full Text] [Related]
39. Immunogenicity of semisynthetic human insulin. Rogala H; Lawecki J; Czyzyk A Acta Med Pol; 1986; 27(1-2):45-50. PubMed ID: 3551505 [No Abstract] [Full Text] [Related]
40. Antibody formation and insulin requirements in diabetic children during treatment with purified commercial pork insulins. Weber B; Tech J; Schmidt H; Oberdisse U Eur J Pediatr; 1978 Jun; 128(2):89-102. PubMed ID: 566669 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]